MedTrace Logo

Efficacy of the AkkoLens IOL in Patients With Cataract

NCT06231784 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2024-01-30

No results posted yet for this study

Summary

The goal of this observational study is to learn about the verification of the effectiveness and visual acuity of LUMINA in patients after lens replacement due to cataracts.

The main questions it aims to answer are:

* Evaluation of the effectiveness of the LUMINA lens in patients after lens replacement due to cataracts
* Evaluation of the accommodative power of the LUMINA lens. Participants will have cataract surgery and the IOL LUMINA will be implanted in the sulcus.

Conditions

  • Cataract

Interventions

DEVICE

LUMINA IOL

A standard technique of phacoemulsification was performed followed by implantation of the Lumina in the sulcus plane of the eye by using a standard disposable injector system with an adapted, proprietary, AkkoLens butterfly cartridge.

Sponsors & Collaborators

  • AkkoLens Clinical bv

    collaborator UNKNOWN

  • Vissum, Instituto Oftalmológico de Alicante

    lead OTHER

Principal Investigators

  • Jorge Alio, MD, PhD · Vissum Instituto Oftalmologico de Alicante

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
81 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-09
Primary Completion
2023-12-31
Completion
2023-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06231784 on ClinicalTrials.gov